Imnovid (Pomalidomide)

Block 1

Imnovid (Pomalidomide) distributor

Imnovid (Pomalidomide) wholesaler, supplier 


Imnovid (Pomalidomide) 

Pomalidomide (marketed as Pomalyst in the U.S. and Imnovid in the EU and Russia) is a thalidomide analogue indicated, in combination with dexamethasone marketed by Celgene.

Imnovid (Pomalidomide) Indications: 

In February 2013 U.S. Food and Drug Administration (FDA) approved Pomalidomide for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.


  • Imnovid (Pomalidomide) 4mg  wholesaler
  • Imnovid (Pomalidomide) 3mg distributor 
  • Imnovid (Pomalidomide) 2mg supplier
  • Imnovid (Pomalidomide) 1m exporter 

Rasso swiss pharma is a Imnovid (Pomalidomide) distributor, wholesaler, supplier.

<< Back to products